Duygu Metin

Duygu Metin

Auto-generated profile, based on publicly available information

Duygu Metin

Department of Radiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
HPHamide Piskinpasa
Hamide Piskinpasa
SDSema Ciftci Dogansen
Sema Ciftci Dogansen
DMDuygu Metin
Duygu Metin
NSNuri Alper Sahbaz
Nuri Alper Sahbaz
AEAyşe Esen
Ayşe Esen
İÇİLKAY ÇAKIR
İLKAY ÇAKIR

11 October 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
EBEvin Bozkur
Evin Bozkur
STSeda Turgut
Seda Turgut
NPNaim Pamuk
Naim Pamuk
HPHamide Piskinpasa
Hamide Piskinpasa
DMDuygu Metin
Duygu Metin
SDSema Ciftci Dogansen
Sema Ciftci Dogansen
Objective: To evaluate the effects of the pandemic process on those with an endocrinological disease that will require close follow-up from the last visit before the pandemic. Materials and methods: Patients of 3,903 with thyroid, calcium-bone metabolism, adrenal gland, pituitary diseases, and neuroendocrine tumor (NET) were retrospectively scanned. The remaining 855 (656 females and 199 males) patients with active disease or who still needed multidisciplinary approaches were included. The number of patients who continued the disease-related medical procedures and [...] ABSTRACT Objective: To evaluate the effects of the pandemic process on those with an endocrinological disease that will require close follow-up from the last visit before the pandemic. Materials and methods: Patients of 3,903 with thyroid, calcium-bone metabolism, adrenal gland, pituitary diseases, and neuroendocrine tumor (NET) were retrospectively scanned. The remaining 855 (656 females and 199 males) patients with active disease or who still needed multidisciplinary approaches were included. The number of patients who continued the disease-related medical procedures and

17 March 2022 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
MEMelike Ersoy
Melike Ersoy
DYDuygu Yegül
Duygu Yegül
HPHamide Pişkinpaşa
Hamide Pişkinpaşa
AGAsuman Gedikbasi
Asuman Gedikbasi
Objectives: We aimed to determine the relationship of Lyso-Gb1 levels, bone biomarkers, and mutation findings with bone marrow burden (BMB) scores. Methods: Lyso-Gb1 and bone biomarkers, and BMB scores of 10 Gaucher type 1 (GD1) patients under enzyme therapy were prospectively evaluated. Results: Ten GD1 patients, aged between 4.5 and 40 (mean 23 ± 11 years), were included in the study. Four patients were homozygous for L444P/L444P, and six patients were compound heterozygous for N370S/R415H. We found positive correlations between pain and BMB scores with Lyso-Gb1 levels (r=0.889, p=0.001 and r=0.701, p=0.035, respectively). There were negative correlations between bone mineral density (BMD) of both the lumbar spine and femoral neck between Lyso-Gb1 levels (r=−0.929, p=0.001 and r=−0.893, p=0.007, respectively). Patients with L444P/L444P mutation had higher Lyso-Gb1 levels and BMB, pain scores and lower BMD measurements than patients with N370S/R415H (p=0.01, p=0.02, p=0.03, p=0.04, p=0.04, respectively). Conclusions: There was an apparent correlation between, Lyso-Gb1 levels, BMB scores and genotype in evaluating bone involvement in Gaucher patients.